glp-1 anesthesia guidelines 2025 How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like New therapeutic agents for type

L-Carnitine: Helps deliver fatty acids into the mitochondria to produce energy, especially useful for athletes participating in endurance exercises or working out vigorously for long hours

Mitochondria, the microscopic powerhouses inside our cells, are responsible for generating adenosine triphosphate (ATP), the energy currency of the body

Impact of medication on protein and amino acid metabolism in the elderly: the sulfur amino acid and paracetamol case

Further, we also compared the deregulated pathways of high ADA expressing (GSE15573) and low ADA expressing (GSE97779 and GSE10500) GEO dataset with our metabolomics datasets of RA patients with high and low ADA levels to identify the common pathways

During the method development stage, the drug's characteristics must be considered